Gen-Xers and Millennials may be at a higher risk for 17 different types of cancer compared to earlier generations, according to a new study published in . The study was led by researchers at the American Cancer Society (快猫短视频).
Gen-Xers refers to members of Generation X, people born between 1965 and 1980. People born between 1981 and 1996 are called Millennials. Researchers found that 17 out of 34 cancer types are on the rise in these two groups when compared to older generations. Cancers of the kidney, pancreas, and small intestine are a few of the cancers becoming more common in younger people.
The study also found that 9 of the 17 cancers that are increasing in young people had been declining in recent years in older generations. These cancers are:
“Gen-Xers and Millennials need to be aware of these trends to modify their risk as much as possible and to be vigilant with cancer screening. This study emphasizes the critical need to study what drives cancer development, particularly in younger people,” said Lan Coffman, MD, PhD, American Society of Clinical Oncology (ASCO) expert and assistant professor of hematology-oncology at the University of Pittsburgh School of Medicine.
Every year in the United States, about 80,000 young adults ages 20 to 39 are diagnosed with cancer. They account for about 4% of all cancer diagnoses. The survival rates for young adults can vary by cancer type, but these rates have not changed much over the past few decades.
However, has shown that cancer is becoming more common in young and middle-aged adults. For example:
Understanding your cancer risk can help you be proactive about your health. Talk with your doctor about your personal cancer risk, especially if cancer runs in your family. Knowing your personal and family health history can help you and your doctor make decisions about your care. Together, you can figure out which cancers you may have a higher risk for and what cancer screening tests and schedule are right for you.
To reduce overall cancer risk, young adults should take steps now, including:
Dr. Coffman is an Associate Editor on .
Developed by the American ?Society of Clinical Oncology?(ASCO).
If this was helpful, donate to help fund patient support services, research, and cancer content updates.